NCT05973851: The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
- State
- Under way
- Phase
- Phase 3
- People
- 418 planned
- Started
- 31 Aug 2024
- Primary completion
- 30 Jun 2028
- Arms
- Major Depressive Disorder EIPT: second-line antidepressant + esketamine nasal spray
- Results
- None posted
- 3 Aug 2023: Trial registered
- 31 Aug 2024: Trial started